UpToDate vs DynaMed: narrative depth versus concise evidence

Neither is better in the abstract; they are built for different reading styles. DynaMed is faster to the recommendation because it is structured for it: a short overview, explicit recommendations and a stated level of evidence, so you can confirm the answer in seconds. UpToDate is richer because it walks you through the reasoning, which is why so many clinicians use it to actually learn a condition rather than just check one.

If your day is high-volume and you mostly need a quick, graded answer, DynaMed suits it. If you value the narrative and the depth, and you want to understand the argument behind the recommendation, UpToDate suits it. A number of clinicians who have access to both use DynaMed to move fast and UpToDate when they want the full picture.

DynaMed is sold mostly through institutions, so most clinicians reach it free through a hospital, library or society rather than paying personally. EBSCO prices individual subscriptions by clinical role at checkout, with a student tier listed around $149 as of July 2026 and higher tiers for practicing clinicians. The American College of Physicians provides DynaMedex to its members as a benefit, which is how a large share of internists access it at no additional cost.

Because individual pricing is role-based and shown at checkout rather than published as one headline number, confirm the current figure on EBSCO's own store before you subscribe, and check whether your institution or professional society already provides access. As with UpToDate, a lot of clinicians pay for a subscription their employer already licenses.

Both are references you consult. Neither watches the prescription you are signing and tells you, unprompted, that the patient is already on an interacting drug, that their renal function makes the standard dose wrong, or that a documented allergy blocks the obvious choice. To get that you have to know to look, several separate times, and the errors that slip through are the checks nobody thought to run.

Prescriber.io is built for exactly that moment. Enter the drug or the scenario and it checks interactions, flags contraindications and allergy blockers, surfaces renal and hepatic dose adjustments and suggests guideline-based alternatives, together, with cited sources. It is decision-support, not autonomous prescribing: every flag is a prompt for the licensed clinician, who verifies against official sources and signs.